A review of lot b902 was performed.There were no nonconformances associated with the lot met release requirements.Trends have been reviewed for the relevant complaint categories and no trends were detected for fever, chills, central line infection, or other adverse event.This assessment is based on information available at the time of this report.No product was returned for evaluation; therefore, it could not be determined if this specific product met specifications.The increase in crp is, most likely, related to the sepsis and not directly to ecp.This incident is being reported because hospital admission occurred with medical intervention.
|